Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and PathAI, a company that develops artificial intelligence technology for pathology, are collaborating with the aim to develop solutions that improve the precision and accuracy of routine diagnosis of cancer and other diseases. 
Global efforts to enhance clinical engagement and accelerate the impact of digital technology in improving patient care, will be boosted by a new bilateral relationship between two organisations dedicated to supporting effective digital uptake in healthcare. Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has signed an agreement to acquire Australian Pharmacy Sleep Services (APSS), a pioneer in pharmacy sleep testing. Headquartered in Sydney, APSS will complement Philips' sleep and respiratory care offering, and will help to accelerate the business' home sleep testing offering through the pharmacy channel in Australia. 
The Lean Startup Academy is an unique opportunity to mature your business by systematically testing your ideas against the market with the support of experts. The course will help you to identify who your prioritary customers should be initially, what is the right value proposition for them and how to reach them. The first Lean Startup Academy will support 10 European eHealth startups to improve their business model through an intensive programme delivered by experienced trainers. 
CUBE's goal is to push the envelope on innovation. Making change and innovation happen in the industry is a tough challenge that takes knowledge, creativity, time and also courage. No Equity. No obligations. No strings attached.
If your startup is outstanding, your products are desperately needed by the industry and the best of all qualifiers, CUBE will give you one million euros in cash.
Merck, a leading science and technology company, announced today the new startups participating in its Accelerator programs in Darmstadt, Germany and Nairobi, Kenya. The two program locations accept startups from different fields within Merck's core specialisms: Darmstadt takes startups from the fields of healthcare, life sciences and performance materials, while Nairobi works exclusively on innovations in digital healthcare. 